TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: blood glucose improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in depressive symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alcohol misuse severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of the macromolecular proton fraction (MPF) in brain tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of participants with co-morbid symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech in Noise Perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of sublobar resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Depression, Anxiety, Stress Scale (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological Resilience Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TMJ pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Satisfaction with Life Scale (SWLS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospital admission or death
Endpoint domain: Mortality/survival
Primary endpoint: First attempt successful intubation attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Atorvastatin/rosuvastatin levels in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Gut health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Immunological indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of adverse events within 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Melbourne Assessment-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Children's Hand Use Experience Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in range of motion for shoulder, elbow, forearm, wrist, and fingers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lower Extremity Functional Mobility Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Semmes-Weinstein Monofilament Testing (SWMT) Score in the Nipple (Area 9)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Word Learning Index
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of Participants in Histologic Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anatomy and variation of venous sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Bio signal data before and after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine-induced humoral and T-cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to resolution of hyperlactemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants that Experienced Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Changes From Baseline in Clinical Laboratory Values and Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with irritation as assessed by the Local Tolerability Scale (LTS)
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of Opioid Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBPS Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Pressure During Pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tampa Scale of Kinesiophobia-11 (TSK-11)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Working Alliance Inventory (WAI)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: complete closure rate of great saphenous vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: accuracy of echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pressure pain threshold and tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of a fracture
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of an infection
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of a hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of nerve damage
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of implant dislocation
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of pulmonary embolism
Endpoint domain: Adverse events/effects
Primary endpoint: Sepsis-related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Illness Perceptions Questionnaire (IPQ scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with miscarriage
Endpoint domain: Mortality/survival
Primary endpoint: Gestation week at miscarriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of lesions with no response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of lesions with partial response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of lesions with complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Penetration-Aspiration Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virtual Reality Sickness Questionnaire
Endpoint domain: Adverse events/effects
Primary endpoint: graybiel scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total score change in SNAP-IV scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Variation in time of 5STS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability via C-SSRS
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability via Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability via Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability via ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety and tolerability via Clinical Laboratory Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic value of serum RAI14 and MACC-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social functioning
Endpoint domain: Life impact
Primary endpoint: Number of patients with significant weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of wheeze during the first two years of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes from baseline mean of daily retrospective total nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baratt Impulsiveness Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Retinal layers thickness measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum level of chemerin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vowel Space Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F2 Slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue and Jaw Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acoustic Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue and Jaw Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of opioid requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in medication-free mean diurnal IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in changepoint task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in history bias task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Management of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative healing rate of mucosal break
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core endurance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flexor extensor isokinetic torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of patients free of major surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Dysfunctional Voiding Symptom Score (DVSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Solicited Local and Systemic Adverse Reaction (ARs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESIs), Medically-Attended AEs (MAAEs) and AEs Leading to Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Caregiver Competence Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Feasibility of the Program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from baseline circulating marker of bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PTSD Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Epigenetic immune age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Color parameters of teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in GABA concentrations in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in GABA-ergic activity in the sensorimotor component of the resting state network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in GABA concentrations in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in GABA concentrations in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Valve-related bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: NPS Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Examination score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Blood transfusion requirement
Endpoint domain: Adverse events/effects
Primary endpoint: Episiotomy site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Early physical component score changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: bacterial phenotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in proteome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in development of hair loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction of bioaerosols
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-surgical recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative ephedrine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion of IgM for COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Sleep latency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Current pain unpleasantness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean difference of m-DASH score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in sleep quality - sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in sleep quality - insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in sleep quality - Morningness or eveningness types
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in sleep quality - Sleep Agenda
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Rate of complete cytoreduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decline in glucose level after reaching peak (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Serum Uric Acid Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Imbalance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of participants with symptoms or changes in vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: number of participants with (serious) adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: discrimination of inflamed and normal tissue based on fluorescence measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain with Kneeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Direct Palpation of Harvest Site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune activation and inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in patient-reported quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area of tissue death induced by TMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset and severity of S-ECC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in parenting skills
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: change from baseline in parenting efficacy
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: change from baseline in child social-emotional behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change from baseline in family conflict
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: change from baseline in parental substance use
Endpoint domain: Adverse events/effects
Primary endpoint: Advancing of PD motor decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed concentration [Cmax]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under concentration curve from time 0 to the last quantifiable concentration [AUClast]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain DETECT questionnaire PDQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Economic burden of palliative care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Suctioning time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of airway bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain measurement using number rating scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter complications
Endpoint domain: Adverse events/effects
Primary endpoint: Self Efficacy for Sexual Healthcare
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitude to Sexual Healthcare
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the Hamilton Anxiety Scale (HAM-A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Generalized Anxiety Disorder 7-Item (GAD-7) scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Endurance: sit up test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power: vertical Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength: 1RM maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Yard dash test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in endothelium-dependent flow-mediated dilation (ED-FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ERG expression in prostatic acinar adenocarcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Attendance of Exercise Sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion in Minutes of Exercise Sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIIT Compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 3-year Event-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Anti-Mullerian hormone (AMH) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Obsessive Compulsive Disorder symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Major adverse cardiac and cerebrovascular events (MACCE)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of angiogenic neutrophils ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: White Spot Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of SpO2/FIO2 Ratio with PaO2/FIO2 Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in smoking initiation behaviour at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in smoking initiation behaviour at 6 months follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of Implementing a Voluntary COVID-19 Point of Care (POC) Screening Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appropriateness of Implementing a Voluntary COVID-19 Point of Care (POC) Screening Program
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Feasibility of Implementing a Voluntary COVID-19 Point of Care (POC) Screening Program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Completed Well Child Check Visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of injected radioactivity entering the brain (%ID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: basic cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in superficial temporal artery diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in dermatitis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diagnostic accuracy of genetic alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stress Reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under The Concentration-time Curve From Time 0 Extrapolated To Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and type of mistakes made during the coffee-tea task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of reward positivity Event-Related Potential signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetic Ketoacidosis Events
Endpoint domain: Adverse events/effects
Primary endpoint: Medio Lateral Stability Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antro Posterior Stability Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The time for first call rescue analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention